completed2023 – 2024Our role: co-PI

Utilising Artificial Intelligence in Cancer Imaging To Improve Patient Outcomes

Bonn-Melbourne Research Excellence Fund (2023-2024)

Project teaser
Figure from Ko et al., J Cachexia Sarcopenia Muscle 2024, CC BY 4.0. Images: Mikael Häggström, M.D, Wikimedia Commons, CC0; Mikael Häggström, M.D, Wikimedia Commons, CC0.

Abstract

Cancer cachexia is a tumour-induced wasting disease that affects about 30% of all patients with cancer. This Bonn–Melbourne initiative, funded by the Bonn–Melbourne Research Excellence Fund of the University of Bonn (2023–2024), brings together clinical, computational (artificial intelligence) and laboratory researchers to improve outcomes for patients with cancer cachexia. The funding broadens digital research links between the two universities and prepares joint grant and conjoint PhD proposals.

Aims

  1. Develop non-invasive screening tools for cancer cachexia using AI-assisted analysis of routine imaging.
  2. Build a deeper understanding of the molecular processes of cancer cachexia using animal models and patient samples.
  3. Raise knowledge and awareness of cachexia through educational events for clinicians, patients and families on its diagnosis and treatment.

Team

The group combines expertise in radiology and image analysis (Hyun Soo Ko, Peter MacCallum Cancer Centre and University of Melbourne; Ulrike Attenberger, University Hospital Bonn), computational science and AI (Shadi Albarqouni, University Hospital Bonn and University of Bonn) and cancer biology and metabolism (Louise Cheng, Peter MacCallum Cancer Centre and University of Melbourne).

Partners:

Outcomes

Perspective

The project established a lasting partnership between the University of Bonn and the University of Melbourne, providing a platform for continued joint research, doctoral training and future collaborative funding applications.

Partner institutions

Publications 3

News, events & teaching